The study by Wang et al. demonstrates that ANRIL is involved in regulating the proliferation and apoptosis of Kasumi-1 cells, which may consequently impact the progression of AML and lead to an unfavorable prognosis (Wang et al., 2024). The gene discussed is CDKN2B-AS1; the disease is acute myeloid leukemia.